Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial

Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial

ABSTRACT: Background: Dipeptidyl peptidase-4 inhibitors provide potent antidiabetic effects in patients with type 2 diabetes mellitus (T2DM), but their role in the presence of nonalcoholic fatty liver disease (NAFLD) is not well-known. Objective: The aim of this clinical trial was to evaluate the e...

Full description

Saved in:
Bibliographic Details
Main Authors: Habib Yaribeygi, PhD, Majid Ramezani, MD, Niki Katsiki, PhD, MD, Majid Mirmohammadkhani, PhD, Narges Sadat Tabaei, Msc
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Current Therapeutic Research
Subjects:
diabetes mellitus
glucagon-like peptide 1
liver function test
nonalcoholic fatty liver disease
sitagliptin
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X24000341
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S0011393X24000341

Similar Items